RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (RPID)

CUSIP: 75340L104

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
-241,171
SEC-reported price per share
$2.90
Number of holders
42
Value change
-$778,137
Number of buys
24
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,037,733

Security key

75340L104

Report period

Q4 2025

Institutions

42

Top holders

10

Ownership snapshot

Top reported holders of RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Robert G. Spignesi Jr.
Disclosed value leader
Bain Capital Life Science...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 6.3% 13D/G row: Robert G. Spignesi Jr. Showing 1-6 of 15 holder rows.

Quick read

Robert G. Spignesi Jr. leads the comparable SEC ownership view at 6.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Robert G. Spignesi Jr.'s linked filing trail.
Comparable ownership Top 5
Robert G. Spignesi Jr. 6.3%
Endeavour Medtech Growth II LP 5.7%
Bain Capital Life Sciences Invest... 21%
ABG-WTT Global Life Science Capit... 4.5%
VANGUARD GROUP INC 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Robert G. Spignesi Jr.
13D/G
SPIGNESI ROBERT G JR
6.3%
$9,133,033
2,647,256 shares
$0 28 Mar 2024
Endeavour Medtech Growth II LP
13D/G
5.7%
$6,545,587
2,257,099 shares
$0 31 Dec 2025
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
21%
$28,171,430
8,434,560 shares
30 Sep 2025
ABG-WTT Global Life Science Capital Partners GP Ltd
13F
Company
13F
4.5%
$6,173,309
1,848,296 shares
30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
2.4%
$3,223,160
965,018 shares
30 Sep 2025
Parkman Healthcare Partners LLC
13F
Company
13F
2.2%
$3,050,900
913,443 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
42
Shares
14,620,290
Rows available
42
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
29
Q4 2025 holders
42
Holder diff
13
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .